Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Author(s) -
J. Beyer,
Laurence Collette,
Nicolas Sauvé,
Gedske Daugaard,
Darren R. Feldman,
Torgrim Tandstad,
А. А. Tryakin,
Olof Ståhl,
Enrique GonzálezBillalabeitia,
Ugo De Giorgi,
Stéphane Culine,
Ronald de Wit,
Aaron R. Hansen,
Marko Bebek,
Angelika Terbuch,
Costantine Albany,
Marcus Hentrich,
Jourik A. Gietema,
Helene F. S. Negaard,
Robert Huddart,
Anja Lorch,
Fay H. Cafferty,
Daniel Yick Chin Heng,
Christopher J. Sweeney,
Eric Winquist,
Michal Chovanec,
Christian D. Fankhauser,
Dan Stark,
Peter Grimison,
Andrea Necchi,
Ben Tran,
Axel Heidenreich,
Jonathan Shamash,
Cora N. Sternberg,
David J. Vaughn,
Ignacio Durán,
Carsten Bokemeyer,
Anna Patrikidou,
Richard Cathomas,
Samson Yaekob Assele,
Silke Gillessen
Publication year - 2021
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.20.03292
Subject(s) - medicine , etoposide , germ cell tumors , oncology , seminoma , chemotherapy
The classification of the International Germ-Cell Cancer Collaborative Group (IGCCCG) has been a major advance in the management of germ-cell tumors, but relies on data of only 660 patients with seminoma treated between 1975 and 1990. We re-evaluated this classification in a database from a large international consortium.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom